Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale 10% owner sold 183,547 shares at an average $25.55 ($4,690,136)
  2. 4 Open-market sale 10% owner sold 136 shares at $25.10 ($3,414)
  3. 4 Open-market sale 10% owner sold 198,006 shares at an average $25.53 ($5,055,851)
  4. 4 Open-market sale 10% owner sold 3,075 shares at $25.30 ($77,812)
  5. 4 Open-market sale 10% owner sold 66,999 shares at an average $25.42 ($1,702,946)
  6. 4 Open-market sale 10% owner sold 311,983 shares at an average $25.76 ($8,037,394)
  7. 4 Open-market sale 10% owner sold 83,067 shares at an average $25.12 ($2,086,630)
  8. 4 Open-market sale 10% owner sold 20,089 shares at an average $25.08 ($503,893)
  9. 4 Grant or award Chief Executive Officer acquired 576,452 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief Technology Officer sold 2,627 shares at $22.77 ($59,817)
  12. 4 Grant or award Chief Financial Officer acquired 66,500 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale Director sold 17,935 shares at $22.59 ($405,062)
  15. 4 Open-market sale EVP & Chief Operating Officer sold 1,482 shares at $22.82 ($33,819)
  16. 4 Open-market buy Director bought 2,500 shares at $22.73 ($56,816)
  17. 4 Open-market sale Chief Medical Officer sold 10,320 shares at an average $23.08 ($238,170)
  18. 4 Open-market sale CFO sold 2,248 shares at $25.97 ($58,387)
  19. 4 Open-market sale Chief Technology Officer sold 2,302 shares at $25.97 ($59,790)
  20. 4 Open-market sale President and CEO sold 27,750 shares at an average $24.53 ($680,747)

Page 8 of 25 · 491 filings